Paranasal sinus tumors: Peter MacCallum Cancer Institute experience

被引:57
作者
Porceddu, S
Martin, J
Shanker, G
Weih, L
Russell, C
Rischin, D
Corry, J
Peters, L
机构
[1] Peter MacCallum Canc Inst, Melbourne, Vic 3002, Australia
[2] Univ Manchester, Sch Med, Manchester, Lancs, England
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2004年 / 26卷 / 04期
关键词
radiotherapy; paranasal sinus tumors; nasal cavity; surgery;
D O I
10.1002/hed.10388
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The purpose of this study was to evaluate the local control, pattern of recurrence, overall survival, and prognostic factors of patients with squamous cell carcinoma (SCC), adenocarcinoma, and undifferentiated carcinoma of the paranasal sinuses (PNS) and nasal cavity (NC) presenting to our center for curative treatment over a 10-year period. Methods. Between 1991 and 2000, 60 patients with SCC (n = 32), adenocarcinorna (n = 25), and undifferentiated carcinoma (n = 3) of the PINS or NC were identified. Forty patients received surgery and postoperative radiotherapy, four, surgery alone; 11, radiotherapy alone; three, radical radiotherapy after surgical recurrence; one, chemoradiotherapy and surgery; and one, induction chemotherapy followed by radiotherapy. Results. Forty-seven patients (78%) were seen with T3-4 disease: however, most (92%) were node negative on initial assessment. The predominant failure pattern was local disease persistence or recurrence. The estimated 2- and 5-year local control rates were 63% and 49%, respectively. Orbital and neural invasion significantly affected local control, The estimated 2- and 5 year overall survival rates were 57% and 40%, respectively. Conclusions. Local failure remains the dominant cause for poor outcome in this group of patients. Because of the proximity of critical normal structures, the ability to perform adequate surgery and to deliver effective radiotherapy is limited in many cases. The use of postoperative concurrent chemoradiotherapy warrants further investigation. (C) 2004 Wiiey Periodicals, Inc.
引用
收藏
页码:322 / 330
页数:9
相关论文
共 20 条
[1]   Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial [J].
Bachaud, JM ;
CohenJonathan, E ;
Alzieu, C ;
David, JM ;
Serrano, E ;
DalySchveitzer, N .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (05) :999-1004
[2]  
BEALE FA, 1983, J OTOLARYNGOL, V12, P377
[3]  
Bernier J., 2001, International Journal of Radiation Oncology Biology Physics, V51, P1, DOI 10.1016/S0360-3016(01)01825-9
[4]  
COOPER JS, 2002, P ASCO, V21, pA226
[5]  
COX DR, 1972, J R STAT SOC B, V34, P187
[6]  
Grant RN, 1970, CA-CANCER J CLIN, V8, P6
[7]  
Harrison LB, 1998, HEAD NECK-J SCI SPEC, V20, P497, DOI 10.1002/(SICI)1097-0347(199809)20:6<497::AID-HED2>3.0.CO
[8]  
2-H
[9]   Does the combination of radiotherapy and debulking surgery favor survival in paranasal sinus carcinoma? [J].
Jansen, EPM ;
Keus, RB ;
Hilgers, FJM ;
Haas, RLM ;
Tan, IB ;
Bartelink, H .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01) :27-35
[10]   MAXILLARY SINUS CARCINOMAS - NATURAL-HISTORY AND RESULTS OF POSTOPERATIVE RADIOTHERAPY [J].
JIANG, GL ;
ANG, KK ;
PETERS, LJ ;
WENDT, CD ;
OSWALD, MJ ;
GOEPFERT, H .
RADIOTHERAPY AND ONCOLOGY, 1991, 21 (03) :193-200